222 Gastrazole, a novel CCKB/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials

I.Chau; D.Cunningham; C.Russell; A.R.Norman; P.Harper; P.Harrison; P.J.Ross; R.Hull; M.Walker; J.Black

首页> 外文期刊>European Journal of Cancer Supplements >222 Gastrazole, a novel CCKB/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials

【24h】

222 Gastrazole, a novel CCKB/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials

机译：222 Gastrazole，一种新型CCKB /胃泌素受体拮抗剂，用于治疗晚期胰腺癌：两项随机对照试验的结果

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements 》 |2003年第5期| 共1页
作者
I.Chau; D.Cunningham; C.Russell; A.R.Norman; P.Harper; P.Harrison; P.J.Ross; R.Hull; M.Walker; J.Black;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Gastrazole (JB95008), a novel CCK2|[sol]|gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials [J] . I Chau, D Cunningham, C Russell, British Journal of Cancer . 2006 ,第8期

机译：Gastrazole（JB95008），一种新型CCK2 | [sol] |胃泌素受体拮抗剂，用于治疗晚期胰腺癌：两项随机对照试验的结果
2. Effect of Degarelix, a Gonadotropin-Releasing Hormone Receptor Antagonist for the Treatment of Prostate Cancer, on Cardiac Repolarisation in a Randomised, Placebo and Active Comparator Controlled Thorough QT/QTc Trial in Healthy Men [J] . Olsson Hakan, Petri Niclas, Erichsen Lars, Clinical drug investigation . 2017 ,第9期

机译：Degarelix，一种促性腺激素释放激素受体拮抗剂用于治疗前列腺癌，对随机，安慰剂和活性比较器中的心脏复放控制的彻底QT / QTC试验
3. Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial [J] . Kordes Sil, Pollak Michael N., Zwinderman Aeilko H., The lancet oncology . 2015 ,第7期

机译：晚期胰腺癌患者的二甲双胍：一项双盲，随机，安慰剂对照的2期试验
4. Design and synthesis of bifunctional peptides:antagonists at CCKA/CCKB receptors and agonists as mu/delta opioid receptors [C] . Richard S.Agnes, Yeon Sun Lee, Peg Davis, the International Peptide Symposium . 2001

机译：双官能肽的设计与合成：Ccka / Cckb受体的拮抗剂和穆/δ阿片受体的激动剂
5. Sexuality and gynaecological cancer: A randomised control trial to evaluate the effectiveness of a group psychoeducational intervention in improving the sexual health of women with gynaecological cancer treated with radiotherapy [D] . Jeffries, Sherryl Anne 2003

机译：性与妇科癌症：一项随机对照试验，旨在评估团体心理教育干预措施对经放射治疗的妇科癌症妇女改善性健康的有效性
6. Gastrazole (JB95008) a novel CCK2/gastrin receptor antagonist in the treatment of advanced pancreatic cancer: results from two randomised controlled trials [O] . I Chau, D Cunningham, C Russell, 2006

机译：Gastrazole（JB95008）一种新型CCK2 /胃泌素受体拮抗剂用于治疗晚期胰腺癌：两项随机对照试验的结果
7. Gastrazole (JB95008), a novel CCK2/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials [O] . Chau, I, Cunningham, D, Russell, C, 2006

机译：Gastrazole（JB95008），一种新型CCK2 /胃泌素受体拮抗剂，用于治疗晚期胰腺癌：两项随机对照试验的结果

222 Gastrazole, a novel CCKB/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials

著录项

相似文献

相关主题

期刊订阅